Showing results (11-20 of 42) with videos related to
Sort By:
Pageof 5
Therapeutic Drug Monitoring|October 18, 2000
High-performance liquid chromatographic method for the determination of colistin in serumP P Le Brun, A I de Graaf, A A VinksTherapeutic Drug Monitoring|January 25, 2005
Cost-effectiveness of therapeutic drug monitoring: a systematic reviewD J Touw, C Neef, A H Thomson, et al.The Journal of Antimicrobial Chemotherapy|July 1, 1997
Continuous infusion of ceftazidime in cystic fibrosis patients during home treatment: clinical outcome, microbiology and pharmacokineticsA A Vinks, R W Brimicombe, H G Heijerman, et al.Therapeutic Drug Monitoring|February 1, 1993
Validation of tobramycin monitoring in adolescent and adult patients with cystic fibrosisD J Touw, A A Vinks, H G Heijerman, et al.Therapeutic Drug Monitoring|April 1, 1996
Prospective evaluation of a dose prediction algorithm for intravenous tobramycin in adolescent and adult patients with cystic fibrosisD J Touw, A A Vinks, H G Heijerman, et al.Clinical Pharmacology and Therapeutics|October 23, 2009
Clinical trial simulations in pediatric patients using realistic covariates: application to teduglutide, a glucagon-like peptide-2 analog in neonates and infants with short-bowel syndromeM S Mouksassi, J F Marier, J Cyran, et al.CPT: Pharmacometrics & Systems Pharmacology|July 26, 2013
Development of a Physiologically-Based Pharmacokinetic Model for Sirolimus: Predicting Bioavailability Based on Intestinal CYP3A ContentC Emoto, T Fukuda, S Cox, et al.Antimicrobial Agents and Chemotherapy|March 18, 2000
Pharmacokinetics of tobramycin in adults with cystic fibrosis: implications for once-daily administrationP M Beringer, A A Vinks, R W Jelliffe, et al.Clinical Pharmacokinetics|January 13, 1999
Pharmacokinetic optimisation of antibacterial treatment in patients with cystic fibrosis. Current practice and suggestions for future directionsD J Touw, A A Vinks, J W Mouton, et al.Clinical Pharmacokinetics|October 6, 2000
Comparative pharmacokinetics of the carbapenems: clinical implicationsJ W Mouton, D J Touzw, A M Horrevorts, et al.Pageof 5